EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Stable, Cap 1-Modified Red Fluorescent Reporter

Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic messenger RNA encoding the mCherry red fluorescent protein, featuring a Cap 1 structure and incorporating 5-methylcytidine (5mCTP) and pseudouridine (ψUTP) for enhanced stability and reduced innate immune activation [ApexBio]. The mRNA is approximately 996 nucleotides and is supplied at ~1 mg/mL in 1 mM sodium citrate buffer, pH 6.4. The Cap 1 structure is enzymatically added, mimicking mammalian mRNA capping, to boost translation efficiency. Modified nucleotides support increased mRNA stability and reduced cytotoxicity in vitro and in vivo [Roach 2024]. A poly(A) tail further enhances translation initiation, making this product a robust tool for molecular and cell biology workflows.

Biological Rationale

Reporter gene systems are essential tools in molecular and cell biology for visualizing gene expression and tracking cellular processes. mCherry is a monomeric red fluorescent protein derived from Discosoma sp. DsRed and emits at a peak wavelength of ~610 nm [FPbase]. Synthetic mRNA encoding fluorescent proteins allows rapid, transient, and non-integrative expression, eliminating the risks of genomic modification. The addition of a Cap 1 structure to in vitro transcribed (IVT) mRNA mimics the natural cap found in eukaryotic mRNAs, enhancing translation and stability [Sahin 2017]. Incorporation of 5mCTP and ψUTP nucleotide analogs further stabilizes the mRNA and suppresses activation of pattern recognition receptors, such as TLR7/8, that detect exogenous RNA [Karikó 2021]. These modifications are especially relevant for applications requiring robust, long-term protein expression in sensitive or primary cell types.

Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)

EZ Cap™ mCherry mRNA is engineered to maximize protein expression while minimizing innate immune responses. The Cap 1 structure is enzymatically added using Vaccinia virus Capping Enzyme (VCE), GTP, S-adenosylmethionine (SAM), and 2´-O-Methyltransferase. This cap modification increases translation initiation by facilitating recruitment of the eukaryotic initiation factor 4E (eIF4E) complex [Sahin 2017]. Substitution of canonical cytidine and uridine residues with 5mCTP and ψUTP, respectively, reduces recognition by toll-like receptors and RIG-I-like helicases, which are primary sensors of foreign RNA in mammalian cells [Karikó 2021]. This leads to decreased production of type I interferons and pro-inflammatory cytokines. The poly(A) tail, enzymatically incorporated, enhances mRNA stability and supports efficient translation re-initiation cycles, further boosting protein output [Karikó 2021].

Evidence & Benchmarks

• Cap 1-structured mRNA demonstrates a 3- to 5-fold increase in translational efficiency compared to uncapped or Cap 0 mRNA in mammalian cells (Sahin 2017).
• 5mCTP and ψUTP nucleotide modifications reduce innate immune activation and double the in vitro stability window at 37°C versus unmodified mRNA (Karikó 2021).
• Synthetic mCherry mRNA (996 nt) produces red fluorescence with a maximal emission at ~610 nm, allowing multiplexing with GFP and other fluorophores (FPbase).
• In nanoparticle delivery formulations, modified mRNA yields >80% encapsulation efficiency and maintains functional protein expression in vitro and in vivo (Roach 2024).
• Poly(A)-tailed, Cap 1 mRNAs exhibit prolonged protein expression in primary human cells, with detectable fluorescence lasting >72 hours post-transfection (Karikó 2021).

For additional benchmarks, see the EZ Cap™ mCherry mRNA (5mCTP, ψUTP): High-Stability Red Fluorescent Reporter, which details immune suppression and stability metrics in live-cell workflows. This article extends those findings by presenting comparative nanoparticle encapsulation and primary cell expression data.

Applications, Limits & Misconceptions

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is designed as a reporter gene for transient fluorescent protein expression in mammalian cells. Key applications include:

• Live-cell imaging and real-time tracking of gene expression.
• Cellular localization studies using mCherry’s ~610 nm emission profile, which is spectrally separated from GFP and CFP (FPbase).
• Functional screening in primary, stem, or sensitive immune cells where DNA transfection or viral vectors may cause genotoxicity.
• Assessment of transfection efficiency and mRNA delivery in nanoparticle or lipid-based platforms (Roach 2024).

Compared to EZ Cap™ mCherry mRNA: Advancing Robust Fluorescent Protein Expression, which focuses on live-cell imaging workflows, this article clarifies performance benchmarks in primary cell and nanoparticle-based delivery models.

Common Pitfalls or Misconceptions

• EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is not suitable for stable, long-term integration; it is designed for transient expression only.
• The mRNA does not self-amplify; expression duration is limited by mRNA stability and cellular turnover.
• Not intended for direct in vivo therapeutic use without regulatory approval and appropriate delivery vehicles.
• Fluorescence intensity depends on transfection efficiency and cell type; low uptake will yield weak signal.
• Storage above -40°C or repeated freeze-thaw cycles will degrade the mRNA and reduce activity.

Workflow Integration & Parameters

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is provided at a concentration of ~1 mg/mL in 1 mM sodium citrate, pH 6.4, and should be stored at or below -40°C. For optimal results, use fresh aliquots and avoid multiple freeze-thaw cycles. Transfection protocols are compatible with lipid-based, polymer-based, and nanoparticle delivery systems. For benchmarking, 0.5–1 µg mRNA per 10⁵ cells is recommended in a 24-well format. Peak fluorescence is typically observed at 12–24 hours post-transfection, with signal persisting up to 72 hours in primary cells [Karikó 2021]. For nanoparticle encapsulation, encapsulation efficiencies exceed 80% with standard lipid or polymeric carriers [Roach 2024].

This article updates the encapsulation and immunogenicity data summarized in EZ Cap™ mCherry mRNA (5mCTP, ψUTP): High-Stability Red Fluorescent Reporter by adding primary literature evidence from nanoparticle-based delivery studies.

Conclusion & Outlook

EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a next-generation reporter gene mRNA with enhanced stability, suppressed innate immune activation, and robust translational efficiency. Its Cap 1 structure and nucleotide modifications make it especially suitable for demanding cell biology and imaging applications. Ongoing research continues to expand its utility in advanced nanoparticle and primary cell delivery systems. For ordering or specifications, see the product page for EZ Cap™ mCherry mRNA (5mCTP, ψUTP).